Annexon Biosciences Raises $125M in Series D

Annexon Biosciences has successfully raised $125M in a Series D at a $750M valuation led by GV, Alta Partners, Omega Funds, Cowen Healthcare Investments, Redmile Group.

Company Overview

Annexon Biosciences is a Biotech company headquartered in 180 Kimball Way, South San Francisco, CA 94080, founded in 2011 with 150+ employees.

Classical complement pathway inhibitors

Fundraising Details

Amount Raised: $125M
Round Type: Series D
Valuation: $750M
Date: 2024-08-18
Investors: GV, Alta Partners, Omega Funds, Cowen Healthcare Investments, Redmile Group

About Annexon Biosciences

Classical complement pathway inhibitors The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: 180 Kimball Way, South San Francisco, CA 94080
Founded: 2011
Team Size: 150+
Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Annexon Biosciences's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Annexon Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $750M valuation marks an important milestone for Annexon Biosciences, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Annexon Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2024-08-18. For more information about Annexon Biosciences, visit their headquarters at 180 Kimball Way, South San Francisco, CA 94080.